Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenwei Hu

Showing results (141-150 of 160) with videos related to

Pageof 16
Sort By:
Genes & Development|September 27, 2017
Gain-of-function mutant p53 activates small GTPase Rac1 through SUMOylation to promote tumor progressionXuetian Yue, Cen Zhang, Yuhan Zhao, et al.
Cell Death & Disease|April 20, 2022
Leukemia inhibitory factor drives glucose metabolic reprogramming to promote breast tumorigenesisXuetian Yue, Jianming Wang, Chun-Yuan Chang, et al.
Nature Communications|October 18, 2014
LIF negatively regulates tumour-suppressor p53 through Stat3/ID1/MDM2 in colorectal cancersHaiyang Yu, Xuetian Yue, Yuhan Zhao, et al.
The Journal of Clinical Investigation|June 2, 2020
Parkin ubiquitinates phosphoglycerate dehydrogenase to suppress serine synthesis and tumor progressionJuan Liu, Cen Zhang, Hao Wu, et al.
American Journal of Human Genetics|April 7, 2009
Winter temperature and UV are tightly linked to genetic changes in the p53 tumor suppressor pathway in Eastern AsiaHong Shi, Si-jie Tan, Hua Zhong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 29, 2021
<i>TP53</i> Gain-of-Function and Non-Gain-of-Function Mutations Are Differentially Associated With Sidedness-Dependent Prognosis in Metastatic Colorectal CancerMinggui Pan, Chen Jiang, Pam Tse, et al.
BJC Reports|November 8, 2024
PTEN pathogenic variants are associated with poor prognosis in patients with advanced soft tissue sarcomaMinggui Pan, Maggie Y Zhou, Chen Jiang, et al.
Nature Communications|June 8, 2021
Tumor suppressor p53 regulates intestinal type 2 immunityChun-Yuan Chang, Jianming Wang, Yuhan Zhao, et al.
Nature Communications|January 20, 2024
Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia in miceXue Yang, Jianming Wang, Chun-Yuan Chang, et al.
BMC Complementary Medicine and Therapies|July 17, 2023
Efficacy and safety of Xian-Lian-Jie-Du optimization decoction as an adjuvant treatment for prevention of recurrence in patients with stage IIIB/IIIC colon cancer: study protocol for a multicentre, randomized controlled trialXuechen Geng, Ziqiang Wang, Li Feng, et al.
Pageof 16

Showing results (141-150 of 160) with videos related to

Sort By:
Pageof 16
Genes & Development|September 27, 2017
Gain-of-function mutant p53 activates small GTPase Rac1 through SUMOylation to promote tumor progressionXuetian Yue, Cen Zhang, Yuhan Zhao, et al.
Cell Death & Disease|April 20, 2022
Leukemia inhibitory factor drives glucose metabolic reprogramming to promote breast tumorigenesisXuetian Yue, Jianming Wang, Chun-Yuan Chang, et al.
Nature Communications|October 18, 2014
LIF negatively regulates tumour-suppressor p53 through Stat3/ID1/MDM2 in colorectal cancersHaiyang Yu, Xuetian Yue, Yuhan Zhao, et al.
The Journal of Clinical Investigation|June 2, 2020
Parkin ubiquitinates phosphoglycerate dehydrogenase to suppress serine synthesis and tumor progressionJuan Liu, Cen Zhang, Hao Wu, et al.
American Journal of Human Genetics|April 7, 2009
Winter temperature and UV are tightly linked to genetic changes in the p53 tumor suppressor pathway in Eastern AsiaHong Shi, Si-jie Tan, Hua Zhong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 29, 2021
<i>TP53</i> Gain-of-Function and Non-Gain-of-Function Mutations Are Differentially Associated With Sidedness-Dependent Prognosis in Metastatic Colorectal CancerMinggui Pan, Chen Jiang, Pam Tse, et al.
BJC Reports|November 8, 2024
PTEN pathogenic variants are associated with poor prognosis in patients with advanced soft tissue sarcomaMinggui Pan, Maggie Y Zhou, Chen Jiang, et al.
Nature Communications|June 8, 2021
Tumor suppressor p53 regulates intestinal type 2 immunityChun-Yuan Chang, Jianming Wang, Yuhan Zhao, et al.
Nature Communications|January 20, 2024
Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia in miceXue Yang, Jianming Wang, Chun-Yuan Chang, et al.
BMC Complementary Medicine and Therapies|July 17, 2023
Efficacy and safety of Xian-Lian-Jie-Du optimization decoction as an adjuvant treatment for prevention of recurrence in patients with stage IIIB/IIIC colon cancer: study protocol for a multicentre, randomized controlled trialXuechen Geng, Ziqiang Wang, Li Feng, et al.
Pageof 16